Trastuzumab (H, 8mg/kg

DRUG2 trials

Sponsors

Western Regional Medical Center, Hebei Medical University Fourth Hospital

Conditions

ER-positive Breast CancerHER2-positive Breast Cancer

Phase 1

Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy

TerminatedNCT02345772

Western Regional Medical CenterER-positive Breast Cancer, HER2-positive Breast Cancer

Start: 2014-07-31End: 2015-11-30Updated: 2018-02-20

Phase 2

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

RecruitingNCT07635342

Hebei Medical University Fourth HospitalHER2-positive Breast Cancer

Start: 2024-04-30End: 2029-12-31Target: 182Updated: 2026-06-09